Korosoglou Grigorios, Shah Saurabh, Vonken Evert-Jan, Gilson Wesley D, Schär Michael, Tang Lijun, Kraitchman Dara L, Boston Raymond C, Sosnovik David E, Weiss Robert G, Weissleder Ralph, Stuber Matthias
Russell H. Morgan Department of Radiology and Radiological Science, Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
Radiology. 2008 Nov;249(2):501-9. doi: 10.1148/radiol.2491071706. Epub 2008 Sep 9.
To evaluate the utility of inversion recovery with on-resonant water suppression (IRON) in combination with injection of the long-circulating monocrystalline iron oxide nanoparticle (MION)-47 for contrast material-enhanced magnetic resonance (MR) angiography.
Experiments were approved by the institutional animal care committee. Eleven rabbits were imaged at baseline before injection of a contrast agent and then serially 5-30 minutes, 2 hours, 1 day, and 3 days after a single intravenous bolus injection of 80 micromol of MION-47 per kilogram of body weight (n = 6) or 250 micromol/kg MION-47 (n = 5). Conventional T1-weighted MR angiography and IRON MR angiography were performed on a clinical 3.0-T imager. Signal-to-noise and contrast-to-noise ratios were measured in the aorta of rabbits in vivo. Venous blood was obtained from the rabbits before and after MION-47 injection for use in phantom studies.
In vitro blood that contained MION-47 appeared signal attenuated on T1-weighted angiograms, while characteristic signal-enhanced dipolar fields were observed on IRON angiograms. In vivo, the vessel lumen was signal attenuated on T1-weighted MR angiograms after MION-47 injection, while IRON supported high intravascular contrast by simultaneously providing positive signal within the vessels and suppressing background tissue (mean contrast-to-noise ratio, 61.9 +/- 12.4 [standard deviation] after injection vs 1.1 +/- 0.4 at baseline, P < .001). Contrast-to-noise ratio was higher on IRON MR angiograms than on conventional T1-weighted MR angiograms (9.0 +/- 2.5, P < .001 vs IRON MR angiography) and persisted up to 24 hours after MION-47 injection (76.2 +/- 15.9, P < .001 vs baseline).
IRON MR angiography in conjunction with superparamagnetic nanoparticle administration provides high intravascular contrast over a long time and without the need for image subtraction.
评估采用共振水抑制的反转恢复序列(IRON)联合注射长循环单晶氧化铁纳米颗粒(MION-47)用于对比剂增强磁共振(MR)血管造影的效用。
实验经机构动物护理委员会批准。11只兔子在注射对比剂前进行基线成像,然后在每千克体重单次静脉推注80微摩尔MION-47(n = 6)或250微摩尔/千克MION-47(n = 5)后的5 - 30分钟、2小时、1天和3天进行连续成像。在临床3.0-T成像仪上进行常规T1加权MR血管造影和IRON MR血管造影。在体测量兔子主动脉的信噪比和对比噪声比。在MION-47注射前后从兔子获取静脉血用于模型研究。
含有MION-47的体外血液在T1加权血管造影上显示信号衰减,而在IRON血管造影上观察到特征性的信号增强偶极场。在体,MION-47注射后T1加权MR血管造影上血管腔信号衰减,而IRON通过同时在血管内提供正信号并抑制背景组织来支持高血管内对比度(注射后平均对比噪声比为61.9±12.4[标准差],基线时为1.1±0.4,P <.001)。IRON MR血管造影的对比噪声比高于常规T1加权MR血管造影(9.0±2.5,与IRON MR血管造影相比P <.001),并且在MION-47注射后持续长达24小时(76.2±15.9,与基线相比P <.001)。
IRON MR血管造影联合超顺磁性纳米颗粒给药可在长时间内提供高血管内对比度,且无需图像减影。